MYGN Financial Facts

Earnings per basic share: 0.67
Research and development expense: 17.09M
See Full Income Statement

Deferred taxes: 6.45M
Total liabilities and stockholders' equity: 823.81M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date 11/5/14 *Est. EPS Growth Rate -9.4% *Last Qtr.
Average EPS % Beat Rate +25.6% Revenue Growth Rate +8.4% *Last Qtr.
Average % Move 1-Wk after EPS +1.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/12/14 Q414 $0.48$0.46 +$0.02$188.8M$187.68M Details
5/6/14 Q314 $0.48$0.45 +$0.03$176.2M$175.23M = Details
2/4/14 Q214 $0.66$0.46 +$0.20$204.06M$176.02M = Details
11/5/13 Q114 $0.68$0.46 +$0.22$202.47M$167.64M = Details
8/13/13 Q413 $0.53$0.44 +$0.09$174.1M$159.87M = Details
2/5/13 Q213 $0.42$0.38 +$0.04$149.1M$143.71M Details
11/5/12 Q113 $0.36$0.32 +$0.04$133.44M$129.43M Details
5/7/13 Q113 $0.46$0.40 +$0.06$156.5M$148.25M Details